Health groups and researchers in Latin America are using artificial intelligence to share sexual and reproductive health information. The work aims to help young and marginalised people who face language barriers, stigma and limited services.
In Peru, TeleNanu is a Quechua-language chatbot that uses generative AI and simple counselling steps. Midwives trained it with World Health Organization and Peru health guidelines. The system gives evidence-based answers and can suggest human counselling when needed.
In October, a Peruvian non-profit launched NOA, an AI platform on WhatsApp, the web and social media. It aims to reach 100,000 adolescents by 2026. Experts say access, biased data and coordination are important challenges.
Difficult words
- artificial intelligence — Computer systems that can perform smart tasks.
- marginalised — People with little social or economic power.
- stigma — A negative social idea about a person or group.
- chatbot — A computer program that chats with people.
- counselling — Help and advice about personal or health problems.
- evidence-based — Based on reliable research or trusted information.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think AI chatbots can help people who speak different languages? Why?
- Would you use a WhatsApp health platform like NOA? Why or why not?
- What problems could make these AI health projects hard to use?
Related articles
AI and Wearable Devices for Type 2 Diabetes
A meta-review from the University at Buffalo examines AI-enhanced wearable devices for Type 2 diabetes and prediabetes. The study finds predictive benefits and important limits, and calls for larger, more transparent studies before routine clinical use.
Exercise helps reduce 'chemo brain' during chemotherapy
Researchers tested a home exercise program during chemotherapy and found patients who followed it kept daily activity and reported clearer thinking. The trial compared a six-week exercise plan with standard care during treatment.
New oral drug approved for sleeping sickness
European regulators approved Acoziborole, a single-dose oral treatment for sleeping sickness after successful trials in the DRC and Guinea. Sanofi will donate doses to WHO, but national approvals and vector control are still needed to reach elimination goals.